Carlsmed Revolutionizes Personalized Surgery with $52.5M Funding
March 19, 2024, 3:31 pm

Location: United States, California, Carlsbad
Employees: 11-50
Founded date: 2018
Total raised: $95M
Carlsmed, a Carlsbad-based medtech company, secures $52.5M in Series C funding to advance personalized surgery. Led by B Capital and U.S. Venture Partners, the funding will propel the commercialization of the aprevo® platform for spine surgery. CEO Mike Cordonnier aims to empower patients with AI-enabled technology. The future of personalized surgery is here.